{"url":"https://lda.senate.gov/api/v1/filings/234b2b96-f1cd-4ecc-aa5f-4de491cffc38/","filing_uuid":"234b2b96-f1cd-4ecc-aa5f-4de491cffc38","filing_type":"RR","filing_type_display":"Registration","filing_year":2020,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/234b2b96-f1cd-4ecc-aa5f-4de491cffc38/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Andrew McKechnie, Partner","dt_posted":"2020-05-04T11:35:59-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1300 CONNECTICUT AVENUE, NW","registrant_address_2":"Suite 600","registrant_different_address":null,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20036","registrant":{"id":20744,"url":"https://lda.senate.gov/api/v1/registrants/20744/","house_registrant_id":31587,"name":"TIBER CREEK GROUP","description":"Government Relations.","address_1":"750 9th Street NW","address_2":"Suite 501","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"GRACE BAUM","contact_telephone":"+1 202-381-6896","dt_updated":"2026-07-20T13:07:00.819992-04:00"},"client":{"id":204274,"url":"https://lda.senate.gov/api/v1/clients/204274/","client_id":1006524,"name":"EMD MILLIPORE","general_description":"Global life sciences company.","client_government_entity":false,"client_self_select":null,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-03-20"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to life sciences product development.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":53494,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"MCKECHNIE","suffix":null,"suffix_display":null},"covered_position":"Health Policy Advisor, Sen. Finance Committee; Legislative Assistant, Senator Norm Coleman; Legislative Assistant, Rep. Jim Ramstad; Bipartisan Medical Technology Caucus","new":true},{"lobbyist":{"id":67494,"prefix":null,"prefix_display":null,"first_name":"KRISTEN","nickname":null,"middle_name":null,"last_name":"HARPER","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":69921,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"LEFFINGWELL","suffix":null,"suffix_display":null},"covered_position":"Director of Member Services Coalitions, House Appropriations Cmte.; CoS, Rep. Kay Granger; Deputy CoS, Rep. Kay Granger; Comms. Director, Rep. Kay Granger; Comms. Director, Rep. Jon Porter; Projects Director/Press Secretary, Rep. Mark Kirk","new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[{"name":"MERCK KGAA","contribution":"0.00","ownership_percentage":"100.00","address":"Frankfurter Strasse 250","city":"Darmstadt","state":null,"state_display":null,"country":"DE","country_display":"Germany","ppb_city":null,"ppb_state":null,"ppb_state_display":null,"ppb_country":"DE","ppb_country_display":"Germany"}],"affiliated_organizations":[]}